1. Benjafield et al., Estimation of the global prevalence and burden of obstructive sleep apnoea: a literature-based analysis, UC San Diego, 2019.
An overnight diagnostic sleep test is necessary to confirm a diagnosis of OSA and evaluate its severity. Sleep apnoea testing is classed across four levels.
Pharmacy Sleep Services offers level 3 testing which can be conducted in the comfort of a patient’s home and does not require a GP referral.
1. Automatic Hypnogram 2. Blood Oxygen Sat (SpO2) 3. EEG, EMG, EOG 4. Heart rate & HRV 5. Snore 6. Movement, Head position
A simple test performed at home
No GP referral required, get tested straight away
Sleep report by a local Sleep Physician
$129RRP
Capturing a minimum of seven key channels of data including:
Long waiting times. $750 plus cost of hospital stay ($250-$500) and ongoing costs of post consultation meetings. Private insurance may cover some of these costs. Capturing between 7-16 channels of data including: 1. Body oxygen levels by measuring light transmission through the finger with an “oximeter” 2. Airflow through the nose 3. Chest and abdomen movements 4. Heart activity via an electrocardiogram (ECG) 5. Brain activity via an electroencephalogram (EEG) 6. Muscle activity via an electromyogram (EMG) 7. Eye activity via an electrooculogram (EOG)
An overnight stay in a sleep hospital monitored by a sleep technologist.
(level 3 sleep testing device)
Clinical studies point towards the efficacy of level 3 testing. Level 3 portable devices showed good diagnostic performance compared with level 1 sleep tests in adult patients with a high pretest probability of moderate to severe OSA. In fact, level 3 clinical studies have been found to not be inferior to PSG testing in terms of acceptance, adherence, time to treatment and functional improvements. Level 3 testing meets and challenges traditional clinical parameters.1
For patients suspected of other types of sleep-disordered breathing, level 1 remains the reference standard.
1. Corral, et. al, Conventional Polysomnography Is Not Necessary for the Management of Most Patients with Suspected Obstructive Sleep Apnoea No inferiority, Randomized Controlled Trial, 2017.
With robust academic literature supporting the use of a level 3 test, the choice is clear. When combined with approved screening methods, STOP-Bang and Epworth Sleepiness Scale, level 3 is as viable as level 1 & 2 testing. The Pharmacy Sleep Services program adheres to this in conjunction with Pharmaceutical Society of Australia (PSA) guidelines for the provision of sleep apnoea services. With Pharmacy Sleep Services, sleep testing is administered with personalised, local and face-to-face support; with a qualified sleep physician.
You are about to visit a Philips global content page
Continue
You are about to visit a Philips global content page
Continue